# Sarclisa Escena

NDC: 0024-0674
Generic name: isatuximab-irfc
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260709

FDA application: BLA761445

## Active ingredients

- ISATUXIMAB: 140 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-0674"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-0674
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07730e8c-1340-4d30-8d71-e20f850db8da